keyword
MENU ▼
Read by QxMD icon Read
search

acute coronary syndrom

keyword
https://www.readbyqxmd.com/read/29933147/i-care-randomized-clinical-trial-integrating-depression-and-acute-coronary-syndrome-care-in-low-resource-hospitals-in-china-design-and-rationale
#1
Shenshen Li, James A Blumenthal, Chuan Shi, Danielle Millican, Xian Li, Xin Du, Anushka Patel, Pei Gao, Elizabeth Delong, Pallab K Maulik, Runlin Gao, Xin Yu, Yangfeng Wu
Depression and acute coronary syndromes (ACS) are both common public health challenges. Patients with ACS often develop depression, which in turn adversely affects prognosis. Low-cost, sustainable, and effective service models that integrate depression care into the management of ACS patients to reduce depression and improve ACS outcomes are critically needed. Integrating Depression Care in ACS patients in Low Resource Hospitals in China (I-CARE) is a multicenter, randomized controlled trial to evaluate the efficacy of an 11-month integrated care (IC) intervention compared to usual care (UC) in management of ACS patients...
May 21, 2018: American Heart Journal
https://www.readbyqxmd.com/read/29931649/one-year-efficacy-and-safety-of-routine-prasugrel-in-patients-with-acute-coronary-syndromes-treated-with-percutaneous-coronary-intervention-results-of-the-prospective-rijnmond-collective-cardiology-research-study
#2
T Yetgin, E Boersma, P C Smits, A G de Vries, E Huijskens, F Zijlstra, M M J M van der Linden, R J M van Geuns
OBJECTIVE: To investigate 1‑year outcomes with routine prasugrel treatment after acute coronary syndrome (ACS) in a large-scale registry. METHODS: The Rijnmond Collective Cardiology Research registry is a prospective, observational study that enrolled 4,258 consecutive ACS patients treated with percutaneous coronary intervention (PCI) with 1‑year follow-up. Patients received prasugrel as first-choice antiplatelet agent, except for increased bleeding risk patients in which clopidogrel was recommended...
June 21, 2018: Netherlands Heart Journal
https://www.readbyqxmd.com/read/29931556/acute-coronary-syndrome-in-cancer-patients
#3
REVIEW
Begum Yetis Sayin, Mehmet Ali Oto
Cardiologists are seeing an increasing number of oncology patients every day, and acute coronary syndrome (ACS) is one of the problems patients encounter during follow-up. Cardio-oncology is the care of patients with cancer and cardiovascular disease, whether overt or occult, already established or acquired during treatment. Cardiovascular complications can occur acutely during or shortly after treatment and persist as long-term effects for months to years after treatment. As a delayed effect of cancer treatment, cardiovascular damage can occur months to years after the initial treatment...
June 22, 2018: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://www.readbyqxmd.com/read/29931511/-essential-cardiac-biomarkers-in-the-differential-diagnosis-of-acute-chest-pain-an-update
#4
M Vafaie, E Giannitsis, H A Katus
Cardiac biomarkers are an integral part of the diagnostic work-up and risk stratification of patients with chest pain. Cardiac troponins are highly sensitive diagnostic biomarkers in patients with acute coronary syndrome and have prognostic value in a multitude of acute and chronic diseases. In patients with suspected pulmonary embolism (PE) D‑dimer can be used together with the Wells score for exclusion of PE. In patients with confirmed PE, B‑type natriuretic peptide (BNP), N‑terminal pro-BNP (NT-proBNP) and heart-type fatty acid binding protein (h-FABP) can be used for risk stratification...
June 21, 2018: Herz
https://www.readbyqxmd.com/read/29931178/coronary-vasospasm-after-burn-injury-first-described-case-series-of-a-lethal-lesion
#5
Derek M Culnan, Rajiv Sood
Burn injuries generate multisystem physiological derangements. The authors present a case series of three patients developing acute coronary syndrome (ACS) stemming from coronary vasospasm (CVS) over a course of 5 months. This etiology of ACS is significant as it has previously not been described in burn patients and requires a different management algorithm than vaso-occlusive disease. All patients were admitted to a single accredited burn unit. Burn mechanisms were flash burn, chemical fire, and house fire...
December 4, 2017: Journal of Burn Care & Research: Official Publication of the American Burn Association
https://www.readbyqxmd.com/read/29931092/japan-united-states-of-america-harmonized-assessment-by-randomized-multicentre-study-of-orbusneich-s-combo-stent-japan-usa-harmonee-study-primary-results-of-the-pivotal-registration-study-of-combined-endothelial-progenitor-cell-capture-and-drug-eluting-stent
#6
Shigeru Saito, Mitchell W Krucoff, Shigeru Nakamura, Roxana Mehran, Akiko Maehara, Hussein R Al-Khalidi, Stephen M Rowland, Gudaye Tasissa, Debbie Morrell, Diane Joseph, Yumiko Okaniwa, Yoshisato Shibata, Barry D Bertolet, Mark D Rothenberg, Philippe Généreux, Hiram Bezerra, David F Kong
Aims: Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (HARMONEE) (NCT02073565) was a randomized pivotal registration trial of the Combo stent, which combined sirolimus and an abluminal bioabsorbable polymer with a novel endoluminal anti-CD34+ antibody coating designed to capture endothelial progenitor cells (EPC) and promote percutaneous coronary intervention (PCI) site healing. Methods and results: Clinically stabilized PCI subjects were randomized 1:1 to receive Combo or everolimus-eluting stents (EES)...
June 21, 2018: European Heart Journal
https://www.readbyqxmd.com/read/29930021/study-of-two-dose-regimens-of-ticagrelor-compared-with-clopidogrel-in-patients-undergoing-percutaneous-coronary-intervention-for-stable-coronary-artery-disease-steel-pci
#7
Rachel C Orme, William A E Parker, Mark R Thomas, Heather M Judge, Kathleen Baster, Wael Sumaya, Kenneth P Morgan, Hannah C McMellon, James D Richardson, Ever D Grech, Nigel M Wheeldon, Ian R Hall, Javaid Iqbal, David Barmby, Julian P Gunn, Robert F Storey
Background -Ticagrelor has superior efficacy to clopidogrel in the management of acute coronary syndromes but has not been assessed in patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD). We compared the pharmacodynamic effects of ticagrelor and clopidogrel in this stable population. Methods -180 aspirin-treated stable CAD patients, who were planned to undergo elective PCI in a single center, were randomized 1:1:1 to either a standard clopidogrel regimen or one of two regimens of ticagrelor, either 90mg (T90) or 60mg twice-daily (T60), both with 180mg loading dose...
June 21, 2018: Circulation
https://www.readbyqxmd.com/read/29929842/left-ventricular-end-diastolic-pressure-and-contrast-induced-acute-kidney-injury-in-patients-with-acute-coronary-syndrome-undergoing-percutaneous-coronary-intervention
#8
Fabio V Lima, Suraj Singh, Puja B Parikh, Luis Gruberg
BACKGROUND: Left ventricular end-diastolic pressure (LVEDP) reflects ventricular performance and volume status. We sought to analyze the relationship between LVEDP and the incidence of contrast-induced acute kidney injury (AKI) in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). METHODS: Between January 2006 and December 2008, a total of 254 patients presenting with an acute coronary syndrome had the LVEDP assessed prior to the intervention...
June 9, 2018: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/29929392/mid-term-beta-blocker-treatment-after-low-risk-acute-coronary-syndrome
#9
Pablo E García-Granja, David Dobarro, Cristina Tapia, Gonzalo Fernández-Palacios, Álvaro Aparisi, Ernesto Del Amo, Marina Revilla, María Azpeitia, Itziar Gómez, María J Rollán, J Alberto San Román
No abstract text is available yet for this article.
January 1, 2018: European Journal of Preventive Cardiology
https://www.readbyqxmd.com/read/29928895/hdl-apoa-i-induces-the-expression-of-angiopoietin-like-4-angptl4-in-endothelial-cells-via-a-pi3k-akt-foxo1-signaling-pathway
#10
Dimitris Theofilatos, Panagiotis Fotakis, Efi Valanti, Despina Sanoudou, Vassilis Zannis, Dimitris Kardassis
BACKGROUND: High Density Lipoprotein (HDL) and its main protein component, apolipoprotein A-I (apoA-I) have numerous atheroprotective functions on various tissues including the endothelium. Therapies based on reconstituted HDL containing apoA-I (rHDL-apoA-I) have been used successfully in patients with acute coronary syndrome, peripheral vascular disease or diabetes but very little is known about the genomic effects of rHDL-apoA-I and how they could contribute to atheroprotection. OBJECTIVE: The present study aimed to understand the endothelial signaling pathways and the genes that may contribute to rHDL-apoA-I-mediated atheroprotection...
June 18, 2018: Metabolism: Clinical and Experimental
https://www.readbyqxmd.com/read/29928315/non-vitamin-k-antagonist-oral-anticoagulant-after-acute-coronary-syndrome-is-there-a-role
#11
REVIEW
Paul Guedeney, Birgit Vogel, Roxana Mehran
Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of non-vitamin K antagonist oral anticoagulant (NOAC) with antiplatelet therapy have been tested in several large phases II and III randomised trials. Overall, current evidence suggests that the use of NOACs on top of DAPT after ACS reduces the rate of recurrent ischaemic events, albeit at the price of increased risk for major bleeding...
May 2018: Interventional Cardiology
https://www.readbyqxmd.com/read/29928314/anticoagulant-therapy-for-acute-coronary-syndromes
#12
REVIEW
Eunice Nc Onwordi, Amr Gamal, Azfar Zaman
Anticoagulation in conjunction with antiplatelet therapy is central to the management of acute coronary syndromes (ACS). When used effectively it is associated with a reduction in recurrent ischaemic events including myocardial infarction and stent thrombosis as well as a reduction in death. Effective ischaemic risk reduction whilst balancing bleeding risk remains a clinical challenge. This article reviews the current available evidence for anticoagulation in ACS and recommendations from the European Society of Cardiology...
May 2018: Interventional cardiology
https://www.readbyqxmd.com/read/29927947/regional-to-tertiary-inter-hospital-transfer-versus-in-house-percutaneous-coronary-intervention-in-acute-coronary-syndrome
#13
Delara Javat, Clare Heal, Jennifer Banks, Stefan Buchholz, Zhihua Zhang
RATIONALE: To address the inaccessibility of interventional cardiac services in North Queensland a new cardiac catheterisation laboratory (CCL) was established in Mackay Base Hospital (MBH) in February 2014. OBJECTIVE: To determine whether the provision of in-house angiography and/or percutaneous coronary intervention (PCI) 1) minimises treatment delays 2) further reduces the risk of mortality, recurrent myocardial infarction (MI) and recurrent ischaemia 3) improves patient satisfaction and 4) minimises cost expenditure compared with inter-hospital transfer for patients with acute coronary syndrome (ACS)...
2018: PloS One
https://www.readbyqxmd.com/read/29926562/-acute-coronary-syndrome
#14
O Gach, Husseini Z El, P Lancellotti
Acute coronary syndromes represent a major cause of mortality in our country. There is a very wide spectrum of clinical presentation since the actual classification of acute coronary syndromes is based on electrocardiographic presentation, that is to say based on absence or presence of ST segment elevation. When dealing with an acute chest pain, once the probability of acute coronary syndrome is established, the emergency care must follow the scientific guidelines. One of the critical steps is represented by the evaluation of ischaemic and hemorrhagic risk in order to tailor optimally antithrombotic and anticoagulation therapies and revascularization timing...
May 2018: Revue Médicale de Liège
https://www.readbyqxmd.com/read/29925187/-a-meta-analysis-on-the-association-between-genetic-polymorphisms-of-osteoprotegerin-and-cardiovascular-disease
#15
J Y Xin, H L Cong
Objective: To explore the association between genetic polymorphisms of rs2073617T/C (950T/C) and rs2073618G/C(1181G/C) in the osteoprotegerin gene and cardiovascular disease with meta-analysis. Methods: A computer-based search for the study of relationship between genetic polymorphisms of rs2073617T/C and rs2073618G/C in the osteoprotegerin gene and cardiovascular disease were performed in electronic databases including China National Knowledge Infrastructure(CNKI), China Biomedical Literature Database, Wanfang Database, Chinese Journal Full-text Database, Embase, PubMed, and Cochrane Library, supplemented by manual search, from the beginning of library to February 28, 2017...
June 24, 2018: Zhonghua Xin Xue Guan Bing za Zhi
https://www.readbyqxmd.com/read/29924791/-algorithm-of-treatment-policy-for-a-femoral-artery-false-aneurysm
#16
A A Fokin, K A Kireev
The purpose of the study was to elaborate an algorithm of treatment policy for post-puncture false aneurysms of the femoral artery (FAFA). The study was performed on the basis of the clinical material over 2014-2017 at the Regional Vascular Centre whose specialists have since 2017 been using the femoral arterial approach (FAA) only if the radial arteries are inaccessible for puncture or for inserting the endovascular tools and appliances. The obtained findings demonstrated that the number of coronary interventions performed with the use of the femoral arterial approach in patients presenting with acute coronary syndrome decreased from a total of 758 (100...
2018: Angiologii︠a︡ i Sosudistai︠a︡ Khirurgii︠a︡, Angiology and Vascular Surgery
https://www.readbyqxmd.com/read/29924379/survival-benefit-from-recent-changes-in-management-of-men-and-women-with-st-elevation-myocardial-infarction-treated-with-percutaneous-coronary-interventions
#17
Łukasz Zandecki, Marcin Sadowski, Marianna Janion, Jacek Kurzawski, Marek Gierlotka, Lech Poloński, Mariusz Gąsior
BACKGROUND: Nowadays, the majority of patients with myocardial infarction with ST-segment elevation (STEMI) are treated with primary percutaneous coronary interventions (pPCI). In recent years, there have been ongoing improvements in PCI techniques, devices and concomitant pharmacotherapy. However, reports on further mortality reduction among PCI-treated STEMI patients remain inconclusive. The aim of this study was to compare changes in management and mortality in PCI-treated STEMI patients between 2005 and 2011 in a real-life setting...
June 20, 2018: Cardiology Journal
https://www.readbyqxmd.com/read/29923156/clinical-efficacy-of-aspirin-with-identification-of-intimal-morphology-by-optical-coherence-tomography-in-preventing-event-recurrence-in-patients-with-vasospasm-induced-acute-coronary-syndrome
#18
Yonggu Lee, Hwan-Cheol Park, Jinho Shin
Using optical coherence tomography (OCT), we found that there were morphological differences in the coronary intima between patients with vasospasm-induced acute coronary syndrome (VACS) and those with stable variant angina. We investigated whether aspirin use would protect against chest pain recurrence in patients with VACS. A retrospective cohort study was performed. Patients with ST-segment elevation who were confirmed to have VACS by a provocation test were included. OCT was performed at the index event and when chest pain recurred to assess intimal morphology...
June 19, 2018: International Journal of Cardiovascular Imaging
https://www.readbyqxmd.com/read/29922739/kounis-syndrome-due-to-hirudotherapy-leech-therapy-in-emergency-department-a-case-report
#19
Tolga Çakmak, İbrahim Çaltekin, Emre Gökçen, Atakan Savrun, Erdoğan Yaşar
Kounis Syndrome is the development of acute coronary syndrome (ACS) because of allergic reactions; allergens, such as foods, insect venom, iodine contrast agent or drugs can cause this syndrome. Hirudotherapy (leech therapy) is increasingly used as a useful therapeutic option in a variety of medical and surgical procedures, and potential complications related to this therapy include Aeromonas species infections, bleeding, anemia and allergic reactions. Here, we present a patient diagnosed as Type 1 Kounis Syndrome after using hirudotherapy for her knee aches...
June 2018: Turkish Journal of Emergency Medicine
https://www.readbyqxmd.com/read/29922732/prognostic-value-of-plasma-st2-in-patients-with-non-st-segment-elevation-acute-coronary-syndrome
#20
Çağrı Kokkoz, Adnan Bilge, Mehmet Irik, Halil I Dayangaç, Mustafa Hayran, Funda Karbek Akarca, Nimet Bilal Erdem, Musa Çavuş
Objective: The aim of this study is to detect plasma ST2 levels in patients who were admitted to emergency department with chest pain and diagnosed with non st segment elevation myocardial infarction (NSTEMI) and to research the relationship between 28-day mortality and ST2 levels. Methods: The present study was conducted at Emergency Department of Celal Bayar University Hafsa Sultan Hospital between September 2015 and January 2016 as a prospective, single-center, cross-sectional study...
June 2018: Turkish Journal of Emergency Medicine
keyword
keyword
35382
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"